Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

No, sorry [Design Issues]

posted by Pharma_88 – India, 2024-05-20 08:50 (765 d 12:24 ago) – Posting: # 24002
Views: 6,365

Dear Ohlbe,

Thank you for response. Could you please let me know how the parallel design will be planned?

As per my understanding...
Screening >> Stabilization Period (with the approved product) >> Randomization (T/R) >> EOS

Regards,
Pharma_88

—
Regards,
Pharma_88

Complete thread:

Single dose PK study on Patients Pharma_88 2024-05-15 05:37
- Single dose PK study on Patients Ohlbe 2024-05-15 09:39
  - Single dose PK study on Patients Pharma_88 2024-05-17 10:06
    - No, sorry Ohlbe 2024-05-17 13:45
      - No, sorryPharma_88 2024-05-20 06:50
        
        Deviating from a guidance Helmut 2024-05-20 07:57
        
        Deviating from a guidance Pharma_88 2024-05-21 08:32
        
        No, sorry Ohlbe 2024-05-21 12:41

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
145 visitors (0 registered, 145 guests [including 34 identified bots]).
Forum time: 21:15 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution. Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz